Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Synaptic plasticity as a therapeutic target in the treatment of autism-related single-gene disorders.

Current pharmaceutical design - 1 Jan 2013

Pignatelli Marco, Feligioni Marco, Piccinin Sonia, Molinaro Gemma, Nicoletti Ferdinando, Nisticò Robert

Abstract excerpt

The term "Autism Spectrum" is often used to describe disorders that are currently classified as Pervasive Developmental Disorders. These disorders are typically characterized by social deficits, communication difficulties, stereotyped or repetitive behaviors and/or cognitive delays or mental retardation; sometimes they present high comorbidity rates with epilepsy. Although these diagnoses share some common...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Allosteric Regulation
Share to Antipsychotic Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Child Development Disorders, Pervasive

Share to Disease Models, Animal

Share to Neuronal Plasticity

Share to Receptor, Metabotropic Glutamate 5

Share to Synapses

Source

Identifiers

PMID: 23432715
DOI: 10.2174/1381612811319360008

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Synaptic plasticity as a therapeutic target in the treatment of autism-related single-gene disorders.PMID 23432715Read ↗

Autism and the synapse: emerging mechanisms and mechanism-based therapies.Semantic proximity Read ↗

Modeling of autism genetic variations in mice: focusing on synaptic and microcircuit dysfunctions.Semantic proximity Read ↗

Genetic ablation of metabotropic glutamate receptor 5 in rats results in an autism-like behavioral phenotype.Semantic proximity Read ↗

Cellular and circuit excitability in rodent models of neurodevelopmental disordersSemantic proximity Read ↗

The promising trajectory of autism therapeutics discovery.Semantic proximity Read ↗

mGluR5 Modulation of Behavioral and Epileptic Phenotypes in a Mouse Model of Tuberous Sclerosis Complex.Semantic proximity Read ↗

Impaired metabotropic glutamate type 5 receptor signaling in the dorsal striatum of the R451C-neuroligin 3 mouse model of Autism Spectrum DisorderSemantic proximity Read ↗

Developing new pharmacotherapies for autism.Semantic proximity Read ↗

Mutations causing syndromic autism define an axis of synaptic pathophysiology.Semantic proximity Read ↗

Translational Mouse Models of Autism: Advancing Toward Pharmacological Therapeutics.Semantic proximity Read ↗

Single-nucleotide polymorphism analysis accurately predicts multiple impairments in hippocampal activity and memory performance in a murine model of idiopathic autism.Semantic proximity Read ↗

Spatial and Temporal Gene Function Studies in Rodents: Towards Gene-Based Therapies for Autism Spectrum Disorder.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.